期刊文献+

反义抑制C-myc蛋白表达对人胆管癌细胞株体外增殖的影响

Effect of Antisense Inhibition of C-myc Protein Expression on the Proliferation of Human Bile Duct Cancer Cells in Vitro
下载PDF
导出
摘要 【目的】探讨反义抑制C-myc蛋白的表达对人胆管癌细胞QBC939体外增殖的影响。【方法】采用常规方法培养QBC939细胞,合成C-mycASODN及Ns0DN,并将其转染QBC939细胞;用Western-blot法检测转染AS()DN组(转染组)、转染NSODN组(无义组)及空白对照组细胞中c-myc蛋白的表达;通过四甲基噻唑蓝(MTT)实验检测各组细胞在体外的存活率。【结果】无义组与空白对照组灰度值比较无显著性差异(P〉0.05);转染组的灰度值显著低于空白对照组(P〈0.01);转染不同浓度(Mmol/L)的cmycASODN后,各组细胞的存活率分别为:0.5组为79.6%、1.0组为75.0%、2.0组为70.9%、4.0组为59.1%、8.0组为47.3%,均显著低于空白对照组(P〈0.01)。【结论】反义抑制c-myc蛋白的表达后,人胆管癌细胞在体外的增殖受到了抑制,且其抑制作用随着c-mycASODN浓度的增加而增强。 [Objective] To explore the effect of antisense inhibition of C-myc protein expression on the pro liferation of human bile duct cancer(QBC939) cells in vitro. [Methods] QBC939 cell was cultured by using the routine method. C-myc ASODN and NSODN were designed and transfeeted into QBC939 cells. Western-blot was used to detect the expression of c-myc in ASODN group(transfection group), NSODN group(nonsense group) and control group. The survival rate of QBC939 cell in vitro was detected by MTT assay. [Results] There was no significant difference in the grayscale value between NSODN group and control group ( P 〉 0.05), and the grayscale value in ASODN group was significantly lower than that of control group( P〈0.01). The cell survival rate after the transfection with different concentration of C-myc ASODN in each group was 79.6'%(0.5μmol/L group), 75. 0%0(1.0 μmol/L group), 70. 9%(2.0 μmol/L group), 59. 1%(4.0 /zmol/L group) and 47.3%(8.0/amol/L group), respectively, which were all significantly lower than those in the control group( P〈0.01). [Conclusion] The antisense inhibition of C myc protein expression can inhibit the proliferation of human bile duct cells in vitro. The inhibition increases with the concentration of C-myc ASODN.
出处 《医学临床研究》 CAS 2011年第6期1070-1072,共3页 Journal of Clinical Research
关键词 胆管癌 原癌基因蛋白质c-myc类/生物合成 cholangiocarcinoma proto oncogene proteins C-myc/BI
  • 相关文献

参考文献9

  • 1OlnesMJ, Erlich R. A review and update on cholangiocarcino ma[J]. Orlcology , 2004, 66 (3) : 167-179.
  • 2李灼日,吴金术,毛先海,田秉璋.C-myc、P16和Bc1-2蛋白在胆管癌中表达及意义[J].中国现代医学杂志,2006,16(22):3427-3430. 被引量:9
  • 3Hatakeyama S , Watanabe M , Fujii Y, et al . Targeted dest ruction of c-Myc by an engineered ubiquitin ligase suppresses cell transformation and tumor formation[J]. Cancer Res, 2005 ,65 (17) :7874-7879.
  • 4王耀辉,孔凡民,佟玉兰.c-myc基因与胆管癌关系的研究[J].中国医科大学学报,2005,34(3):248-248. 被引量:7
  • 5Blagosklonny MV , Prabhu NS , El Deiry MS. Defects in p21WAFI/CIP1. Rb. and C-rnyc signaling in phorbol ester re- sistant cancer cells[J], CancerRes ,1997 , 57 (2) : 320-325.
  • 6Robet WM, Philip LF , Inder MV , et al . Cationic liposome mediated RNA transfection[J]. Proc Natl Acad Sci USA, 1989 , 86(16) : 6077-6081.
  • 7Luscher B, Eisenman RN. New light on Myc and Myb. Part 1. Myc[J]. Genes Dev , 1990, 4(9) : 2025-2035.
  • 8Dwyer J, Li H, Xu D, et al . Transcriptional regulation of te lomerase activity: roles of the Ets transcription factor family [J]. Ann N Y Acad Sci ,2007,1114(1):36-47.
  • 9Knoepfler PS. Myc goes global 1 new tricks for an old oncogene [J]. Cancer Re,5 ,2007,67(11)1 5061-5063.

二级参考文献12

  • 1Marcll KB. MYC. Function and regulation[J]. Annu Rev Biochem,1992,61 (25) : 809 - 810.
  • 2Hann SR, Thompson CB, Eisenman RN. C-myc oncogene protein synthesis is independent of the cell in human and avian cell[J]. Nature, 1995,314 (23) :366 - 369.
  • 3Blackwood EM, Eisenman RN. Max :a helix-loop-helix ripper protein that forms a sequence specific DNA-binding complex with myc[ J ].Science, 1991,251 (8) : 1211 - 1217.
  • 4VORAVUD N, FOSTER CS, GLIBERTSON JA, et al. Oncogene expression in cholangiocarcinoma and in normal hepatic development[J]. Hum Pathol, 1989, 20(2): 1163.
  • 5YOSHIDA S, IODOROKI T, ICHIKAWA Y, et al. Mutations of P16 Ink4/CDKN2 and P15InK4B/MTS 2 genes in biliary tract cancers[J]. Cancer Res, 1995, 55(13): 2756.
  • 6TSUJIMOTO Y, FINGER LR, YUNISJ, et al. Cloning of the chromosome break point of neoplastic B ceils with the (14:18) chromosome translocation[J]. Science, 1984, 226(4678): 1097.
  • 7LI XL, HAO YD, ZOU JX, et al. Relation of C-myc,Bcl-2 expression with the biologic behavior of gastric cancer and cell apoptosis[J]. New gastric disease, 1997, 2(12): 773.
  • 8SAEGUSA M, TAKANO Y, WAKABAYASHI T, et al. Apoptosis in gastric carcinoma and its association with cell proliferation and differentiation[J]. Jpn J Cancer Res, 1995, 86(8): 743.
  • 9HINO N, HIGASHI T, NOUSO K, et al. Apoptosis and proliferation of human hepatocellular Carcinoma[J]. Liver, 1996, 16(2): 123.
  • 10XU HY, WANG WL, YAN QG, et al. Expression of anti-apoptosis gene bcl-2 in primary gall bladder cancer and its clinic value[J]. Chinese journal of general surgery fundation and clinic,1998, 59(2): 73.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部